Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Salt-kneading: alternative sizing of active pharmaceutical ingredients

M. Šimek, J. Vyňuchal, L. Tomášová,

. 2016 ; 21 (8) : 972-979. [pub] 20150912

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17014256

The most of currently produced active pharmaceutical ingredients (APIs) are poorly soluble in the human body. One of the options how to increase their dissolution rate is reducing their particle size. If very small particles of API are desired, traditional milling methods often cause smeared, agglomerated or non-flowing particles due to the forces applied. We tried to compare some of milling methods with the salt-kneading method, which is not typically used in the pharmaceutical industry. Salt-kneading process is driven by several variable parameters (e.g. the amount, hardness and particle size of the salt-kneading material), which influence the degree of size reduction of API particles which are chafed by a surplus of salt-kneading material. A model poorly-soluble API was separately processed with oscillation mill, vibratory mill and kneader; and the morphology, size distribution and solid form of prepared particles were analyzed. Our basic variation of salt-kneading parameters showed the potential of the salt-kneading method, which appears a very effective method of API controlled reduction. The final size can be modified according to the amount and properties of the salt-kneading material. The availability of such a method equips pharmaceutical scientists with a size-reduction method that provides very small, rounded and free-flowing particles of the poorly soluble API and reduces non-preferred needle shape.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17014256
003      
CZ-PrNML
005      
20170418105926.0
007      
ta
008      
170413s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.3109/10837450.2015.1086371 $2 doi
035    __
$a (PubMed)26365246
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Šimek, Michal $u a Department of Solid State Chemistry , University of Chemistry and Technology Prague , Prague , Czech Republic. b Zentiva k.s. , Prague , Czech Republic.
245    10
$a Salt-kneading: alternative sizing of active pharmaceutical ingredients / $c M. Šimek, J. Vyňuchal, L. Tomášová,
520    9_
$a The most of currently produced active pharmaceutical ingredients (APIs) are poorly soluble in the human body. One of the options how to increase their dissolution rate is reducing their particle size. If very small particles of API are desired, traditional milling methods often cause smeared, agglomerated or non-flowing particles due to the forces applied. We tried to compare some of milling methods with the salt-kneading method, which is not typically used in the pharmaceutical industry. Salt-kneading process is driven by several variable parameters (e.g. the amount, hardness and particle size of the salt-kneading material), which influence the degree of size reduction of API particles which are chafed by a surplus of salt-kneading material. A model poorly-soluble API was separately processed with oscillation mill, vibratory mill and kneader; and the morphology, size distribution and solid form of prepared particles were analyzed. Our basic variation of salt-kneading parameters showed the potential of the salt-kneading method, which appears a very effective method of API controlled reduction. The final size can be modified according to the amount and properties of the salt-kneading material. The availability of such a method equips pharmaceutical scientists with a size-reduction method that provides very small, rounded and free-flowing particles of the poorly soluble API and reduces non-preferred needle shape.
650    _2
$a pomocné látky $x chemie $7 D005079
650    _2
$a velikost částic $7 D010316
650    _2
$a léčivé přípravky $x chemie $7 D004364
650    _2
$a chlorid sodný $x chemie $7 D012965
650    _2
$a rozpustnost $7 D012995
650    _2
$a farmaceutická technologie $x metody $7 D013678
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vyňuchal, Jan $u c SBU Pigments and Dyes, Synthesia a.s. , Pardubice , Czech Republic. d Faculty of Chemical Technology , University of Pardubice , Pardubice , Czech Republic , and.
700    1_
$a Tomášová, Lea $u e Tomášová Lea s.r.o., Pardubice-Bílé předměstí , Czech Republic.
773    0_
$w MED00004889 $t Pharmaceutical development and technology $x 1097-9867 $g Roč. 21, č. 8 (2016), s. 972-979
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26365246 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170418110234 $b ABA008
999    __
$a ok $b bmc $g 1200721 $s 975034
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 21 $c 8 $d 972-979 $e 20150912 $i 1097-9867 $m Pharmaceutical development and technology $n Pharm Dev Technol $x MED00004889
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...